Your browser doesn't support javascript.
loading
No Patient Left Behind: A Novel Paradigm to Fulfill Hepatitis C Virus Treatment for Rural Patients.
Gormley, Mirinda Ann; Moschella, Phillip; Cordero-Romero, Susan; Wampler, Wesley R; Allison, Marie; Kitzmiller, Katiey; Estes, Luke; Heo, Moonseong; Litwin, Alain H; Roth, Prerana.
Affiliation
  • Gormley MA; Department of Emergency Medicine, Prisma Health Upstate, Greenville, South Carolina, USA.
  • Moschella P; Department of Emergency Medicine, School of Medicine-Greenville, University of South Carolina, Greenville, South Carolina, USA.
  • Cordero-Romero S; School of Health Research, Clemson University, Clemson, South Carolina, USA.
  • Wampler WR; Department of Emergency Medicine, Prisma Health Upstate, Greenville, South Carolina, USA.
  • Allison M; Department of Emergency Medicine, School of Medicine-Greenville, University of South Carolina, Greenville, South Carolina, USA.
  • Kitzmiller K; School of Health Research, Clemson University, Clemson, South Carolina, USA.
  • Estes L; Department of Emergency Medicine, Prisma Health Upstate, Greenville, South Carolina, USA.
  • Heo M; Department of Public Health Sciences, Clemson University, Clemson, South Carolina, USA.
  • Litwin AH; Department of Ambulance Services, Prisma Health Upstate, Greenville, South Carolina, USA.
  • Roth P; Department of Internal Medicine, Prisma Health Upstate, Greenville, South Carolina, USA.
Open Forum Infect Dis ; 11(5): ofae206, 2024 May.
Article de En | MEDLINE | ID: mdl-38737428
ABSTRACT

Background:

This study evaluates a novel multidisciplinary program providing expanded access to hepatitis C virus (HCV) treatment for rural Appalachian patients in South Carolina. This program identified patients via an opt-out emergency department screening program, and it aimed to achieve HCV cure by using community paramedics (CPs) to link and monitor patients from treatment initiation through 12-week sustained virologic response (SVR).

Methods:

Patients aged ≥18 years who were HCV RNA positive were eligible for enrollment if they failed to appear for a scheduled HCV appointment or reported barriers to accessing office-based treatment. CPs provided home visits (initial and 4, 12, and 24 weeks) using a mobile Wi-Fi hotspot to support telemedicine appointments (compliant with the Health Insurance Portability and Accountability Act) and perform focused physical assessments, venipuncture, and coordinated home delivery of medications. Statistics described participant characteristics, prevalence of SVR, and patient satisfaction results at 12 weeks posttreatment.

Results:

Thirty-four patients were eligible for SVR laboratory tests by 31 August 2023; the majority were male (61.7%) and White (64.7%) with an average age of 56 years (SD, 11.7). Twenty-eight (82.4%) completed treatment and achieved 12-week SVR. Six (17.6%) were lost to follow-up. Two-thirds strongly agreed that they were satisfied with the overall care that they received, and half strongly agreed that their overall health had improved.

Conclusions:

This CP-augmented treatment program demonstrated success curing HCV for rural patients who lacked access to office-based treatment. Other health care systems may consider this novel delivery model to treat hard-to-reach individuals who are HCV positive.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Open Forum Infect Dis Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Open Forum Infect Dis Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique